Please use this identifier to cite or link to this item:
Scopus Web of ScienceĀ® Altmetric
Type: Journal article
Title: Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)
Author: Hutchinson, M.
Lewis, S.
Coats, B.
Skyba, D.
Crysdale, N.
Berkelhammer, D.
Brzeski, A.
Northcutt, A.
Vietz, C.
Judd, C.
Maier, S.
Watkins, L.
Johnson, K.
Citation: Brain, Behavior, and Immunity, 2009; 23(2):240-250
Publisher: Academic Press Inc
Issue Date: 2009
ISSN: 0889-1591
Statement of
Mark R. Hutchinson, Susannah S. Lewis, Benjamen D. Coats, David A. Skyba, Nicole Y. Crysdale, Debra L. Berkelhammer, Anita Brzeski, Alexis Northcutt, Christine M. Vietz, Charles M. Judd, Steven F. Maier, Linda R. Watkins and Kirk W. Johnson
Abstract: Morphine-induced glial proinflammatory responses have been documented to contribute to tolerance to opioid analgesia. Here, we examined whether drugs previously shown to suppress glial proinflammatory responses can alter other clinically relevant opioid effects; namely, withdrawal or acute analgesia. AV411 (ibudilast) and minocycline, drugs with distinct mechanisms of action that result in attenuation of glial proinflammatory responses, each reduced naloxone-precipitated withdrawal. Analysis of brain nuclei associated with opioid withdrawal revealed that morphine altered expression of glial activation markers, cytokines, chemokines, and a neurotrophic factor. AV411 attenuated many of these morphine-induced effects. AV411 also protected against spontaneous withdrawal-induced hyperactivity and weight loss recorded across a 12-day timecourse. Notably, in the spontaneous withdrawal study, AV411 treatment was delayed relative to the start of the morphine regimen so to also test whether AV411 could still be effective in the face of established morphine dependence, which it was. AV411 did not simply attenuate all opioid effects, as co-administering AV411 with morphine or oxycodone caused three-to-five-fold increases in acute analgesic potency, as revealed by leftward shifts in the analgesic dose response curves. Timecourse analyses revealed that plasma morphine levels were not altered by AV411, suggestive that potentiated analgesia was not simply due to prolongation of morphine exposure or increased plasma concentrations. These data support and extend similar potentiation of acute opioid analgesia by minocycline, again providing converging lines of evidence of glial involvement. Hence, suppression of glial proinflammatory responses can significantly reduce opioid withdrawal, while improving analgesia.
Keywords: Microglia
DOI: 10.1016/j.bbi.2008.09.012
Appears in Collections:Aurora harvest
Pharmacology publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.